Wuhan Jianmin Zhongwei Pharmaceutical Co., Ltd. is a high-tech enterprise integrating the production, sales and research and development of drugs, health products, medical devices, etc. The company is located at No. 5, Fengting Road, Wuhan Economic and Technological Development Zone, surrounded by green water and green mountains in the scenic northwest of the Yangtze River and beside Wuhan West Ring Expressway.
The company was founded in 2006. Through more than 10 years of development, the company has a strong economic and technological foundation. In order to effectively expand, expand and strengthen various businesses in the pharmaceutical field, the company integrates various resources. Since 2014, it has invested hundreds of millions of yuan in Wuhan Economic and Technological Development Zone and built a modern pharmaceutical science and technology park with high standards. The Science Park covers an area of 50 mu, with a building area of 30000 square meters.
The company passed the new version of GSP certification in September 2015, obtained the drug production license in October 2016, and passed the new version of GMP certification in May 2017.
The business scope of the company covers the production of tablets, hard capsules and granules (including the extraction of traditional Chinese medicine), the wholesale of prepared slices of traditional Chinese medicine, proprietary Chinese medicine, chemical drugs, antibiotics, biochemical drugs, biological drugs (including refrigerated and frozen drugs), Class I, Class II, Class III medical devices and cosmetics, and the research and development of drugs.
The company has established production lines for Chinese medicine processing, Chinese medicine extraction, granules, tablets, capsules, etc. and has passed the new version of GMP certification. The production line for chemical APIs is under construction. There are more than 400 sets of production equipment, including multi-function extracting cans, spray drying granulators, high-speed tablet presses, automatic packaging lines, etc; There are more than 100 sets of precision instruments and equipment for thin layer, gas phase, liquid chromatography, infrared, ultraviolet and other inspection and research and development. The company has an annual processing capacity of more than 1500 tons of traditional Chinese medicine, an annual extraction capacity of about 1000 tons of traditional Chinese medicine, an annual production capacity of 200 tons of granules, 120 million tablets and 50 million capsules.
The company mainly produces 16 kinds of drugs and health products, including Yixin Badiran Jibuya Granules, Tongzhi Surunjiang Tablets and Capsules, Baishou Xiata Hot Tablets, and sells more than 30 kinds of drugs, including Kangai Injection, Xiyanping Injection, Xuebijing Injection; There are also more than 10 varieties of products under development, including traditional Chinese medicine and chemical medicine.
The company takes "products, the benefits of the world, quality, and the foundation of business" as its quality policy, "authentic products, craftsman spirit, and honest enterprises" as its core value, and serves the public health with excellent products!